Glomerulonephritis Flashcards

1
Q

how does nephrotic syndrome arise

A

when the basement membrane in glomerulus becomes highly permeable
- proteinuria >3.5g of protein in 24 hrs = frothy urine
- hypoalbumiaemia < 30g per litre
- peripheral oedema
- hypercholesterolaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are complications of nephrotic syndrome

A
  • higher risk of infection
  • VTE
  • progression of cKD
  • HTN
  • hyperlipidaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the most common cause of nephrotic syndrome in children

A

minimal change disease
- usually idiopathic
- treated w steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the most common causes of nephrotic syndrome in adults

A
  • FSGS: idiopathic or secondary to infection, malignancy, drugs
  • membranous nephropathy
  • HSP
  • infection e.g. HIV

  • membranoproliferative GN but more common in nephritic syndrome
  • amyloidosis/myeloma may have nephrotic range proteinuria but not necessarily other features
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the features of nephritic syndrome

A
  • haematuria
  • oliguria
  • proteinuria
  • fluid retention
  • AKI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the most common cause of primary GN

A

IgA nephropathy or Berger’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how does IgA typically present and what are investigatio findings

A
  • patient in 20s presenting w episodic gross haematuria or directly after URT, GI infection or strenuous infection
  • histology: IgA deposits in glomeruli and mesangial proliferation
  • normal C3,C4
  • asymptomatic microhaematuria w intermittent visible haematuria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the treatment of IgA nephropathy

A

supportive therapy
- ACEi/ARB for proteinuria/HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

when does post-strep GN present and who does it commonly affect

A

weeks after Group A B haemolytic strep infection
- 1-2 wks post tonsilitis/pharyngitis
- 3-4 wks post impetigo/cellulitis
- affects children 3-12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are investigation findings of PSGN

A
  • positive anti-strep antibodies (ASO titre)
  • low serum C3
  • biopsy: immune complex deposition IgG, IgM, C3
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the treatment of PSGN

A

usually self-limiting but supportive therapy:
- ACEi/ARB for proteinuria/HTN
- low sodium diet
- if ESRF then RRT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

give 3 examples of small vessel vasculitis aka ANCA associated cellulitis

A
  • granulomatosis w polyagiitis
  • microscopic polyangiitis
  • eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

granulomatosis with polyangiitis (GPA)
- key features
- investigation findings
- treatment

A
  • features: pulmonary and nasopharyngeal involvement e.g. nasal ulcers/polyps
  • investigation: c-ANCA, biopsy shows segmental necrotising GN
  • ✅: immunosuppression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

microscopic polyangiitis
- key features
- investigation findings
- treatment

A
  • features: usually only mild resp symptoms
  • investigation: p-ANCA (MPO), biopsy shows segmental necrotising GN
  • ✅: immunosuppression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Churg-Strauss syndrome
- key features
- investigation findings
- treatment

A
  • features: asthma, allergic rhinitis, purpura, peripheral neuropathy
  • investigations: p-ANCA, eosinophilia, focal segmental necrotising GN
  • ✅immunosuppression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what happens in Goodpasture syndrome aka anti-GBM disease

A
  • anti-GBM antibodies against type IV collagen attack the glomerulus and pulmonary basement membranes
  • pulmonary haemorrhage + haemoptysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are the investigation findings of anti-GBM disease

A
  • anti-GBM antibodies
  • pulmonary infiltrates on CXR
  • biopsy: linear deposition of IgG along basement membrane
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is the treatment of Goodpasture’s syndrome

A
  • plasma exchange
  • immunosuppression e.g. cyclosphophamide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is thin basement membrane disease due to

A
  • hereditary
  • abnormalities of type IV collagen
20
Q

what are the investigation findings of thin basement membrane disease

A
  • persistent microscopic haematuria - possible visible intermittent haematuria
  • biopsy: diffuse thinning of GBM
21
Q

what is the treatment of thin basement membrane disease

A
  • monitor renal function
  • supportive treatment
22
Q

what is alport syndrome

A

X-linked so usually affects males
- mutation in gene coding for type V collagen
- associated with hearing loss and abnormalities of the eyes
- often leads to ESRF

23
Q

what are the investigation findings of alport syndrome

A
  • persistent microscopic haematuria w intermittent visible haematuria
  • sensorineural hearing loss
  • biopsy: splitting of GBM and alternating thickening and thinning of GBM
  • genetic studies - FHx
24
Q

what is the treatment of alport syndrome

A
  • supportive treatment
  • RRT
  • renal transplant: can lead to Goodpasture’s
25
Q

what are the investigation findings of lupus nephritis

A
  • ANA & anti-dsDNA positive
  • biopsy: 6 different classes of lupus nephritis
26
Q

what is the treatment of lupus nephritis

A
  • supportive therapy
  • immunosuppressive therapy based on classification/presentation
27
Q

what is supportive therapy in the management of GN

A
  • If suspect GN – discuss with Renal team
  • MDT approach depending on underlying diagnosis
  • ACEi/ARB for proteinuria Control BP
  • Salt and water restriction if volume overloaded
  • Diuretics for fluid overload
  • If hypoalbuminaemic <20g/dl then higher risk for VTE – consider therapeutic LMWH
  • Statins for hypercholesterolaemia
28
Q

what is immunosuppressive therapy in the management of GN

A
  • Specific to cause of GN – decided by Renal team (+/- Respiratory / Rheumatology teams if lung or systemic involvement )
  • Oral Corticosteroids, IV pulsed methylprednisolone, Cyclophosphamide, Tacrolimus, Ciclosporin, Rituximab, MMF, Azathioprine
29
Q

what is invasive therapy in the management of GN

A
  • Renal replacement therapy/haemodialysis for those in severe AKI or ESRF
  • Plasma exchange for AAV (with lung involvement), anti-GBM
30
Q

what is one of the main complication of anti-GBM syndrome and what factors increase the risk of this

A

pulmonary haemorrhage
* smoking
* lower respiratory tract infection
* pulmonary oedema
* inhalation of hydrocarbons
* young males

31
Q

what are the causes of membranous nephropathy

5 categories

A
  • idiopathic: due to anti-phospholipase A2 antibodies
  • infections: hepatitis B, malaria, syphilis
  • malignancy (in 5-20%): prostate, lung, lymphoma, leukaemia
  • drugs: gold, penicillamine, NSAIDs
  • autoimmune diseases: systemic lupus erythematosus (class V disease), thyroiditis, rheumatoid
32
Q

what is the managment of membranous nephropathy (3)

A
  • all pt receive ACEi/ARB: shown to reduce proteinuria and improve prognosis
  • immunosuppression: combination of corticosteroid + another e.g. cyclophosphamide
  • consider anticoagulation for high-risk patients
33
Q

what are the causes of FSGS

A
  • idiopathic
  • secondary to other renal pathology e.g. IgA nephropathy, reflux nephropathy
  • HIV
  • heroin
  • Alport’s syndrome
  • sickle-cell
34
Q

in what setting is there a high recurrence rate of FSGS

A

renal transplant

35
Q

what does renal biopsy of FSGS show

A
  • focal and segmental sclerosis and hyalinosis on light microscopy
  • effacement of foot processes on electron microsocopy
36
Q

what is the management of FSGS

A

steroids +/- immunosuppression

37
Q

what does RPGN describe

A

a rapid loss of renal function associated with the formation of epithelial crescents in the majority of glomeruli

38
Q

what are 2 main causes of RPGN

A
  • Goodpasture’s syndrome
  • Wegener’s granulomatosis
39
Q

what are the features of RPGN

A
  • those of nephritic syndrome: haematuria + red cell casts, proteinuria, HTN, oliguria
  • features specfic to underlying cause: haemoptysis with Goodpasture’s, vasculitic rash or sinusitis with Wegener’s
40
Q

what are differences between IgA nephropathy and PSGN

A
  • IgA onset develops 1-2 days after URTI vs PSGN develops 1-2 weeks after URTI
  • PSGN associated low complement levels
  • main symptom in PSGN is proteinuria
41
Q

when does Alport’s syndrome usually present and what features may be present

A
  • microscopic haematuria
  • progressive renal failure
  • bilateral sensorineural deafness
  • lenticonus: protrusion of lens surface into the anterior chamber
  • retinits pigmentosa
42
Q

what is the treatment of proteinuria (2)

A
  1. ACEi or ARBs: 1st line in pt w co-existent HTn + CKD
  2. SGLT-2 inhibitors
43
Q

how do SGLT2 inhibitors help in the management of proteinuria

A
  • mainly act by blocking reabsorption of glucose in PCT which lowers the renal glucose threshold –> glycosuria
  • by blocking the co-transporter, they also reduce Na+ reabsorption –> natriuresis reduces the intravascular volume + BP
  • but also inc delivery of Na+ to the macula densa cells which normalises tubuloglomerular feedback and reduces intraglomerular pressure
44
Q

how does nephrotic syndrome predispose to thrombosis

A

loss of antithrombin III, protein C & S with an associated rise in fibrinogn levels

LMWH

45
Q

how does anti-GBM disease present

A

the disease affects type IV collagen that is found in both the kidneys and the lungs which causes chest symptoms such as haemoptysis, coughing and chest pain